Join

Compare · EVT vs HQH

EVT vs HQH

Side-by-side comparison of Eaton Vance Tax Advantaged Dividend Income Fund (EVT) and abrdn Healthcare Investors Shares of Beneficial Interest (HQH): market cap, price performance, sector, and recent activity on the wire.

Summary

  • Both EVT and HQH operate in Finance Companies (Finance), so they compete in similar markets.
  • EVT is the larger of the two at $2.02B, about 2.2x HQH ($899.1M).
  • Over the past year, EVT is up 15.5% and HQH is up 22.8% - HQH leads by 7.3 points.
  • Both names hit the wire about 2 times in the past 4 weeks.
PerformanceEVT+15.48%HQH+22.76%
2025-06-03+0.00%2026-06-03
MetricEVTHQH
Company
Eaton Vance Tax Advantaged Dividend Income Fund
abrdn Healthcare Investors Shares of Beneficial Interest
Price
$27.00+0.04%
$18.93-1.10%
Market cap
$2.02B
$899.1M
1M return
+2.51%
-4.92%
1Y return
+15.48%
+22.76%
Industry
Finance Companies
Finance Companies
Exchange
NYSE
NYSE
IPO
2003
1987
News (4w)
2
2
Recent ratings
0
0
EVT

Eaton Vance Tax Advantaged Dividend Income Fund

Eaton Vance Tax-Advantaged Dividend Income Fund is a closed-ended equity mutual fund launched and managed by Eaton Vance Management. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating across the diversified sectors. The fund primarily invests in dividend paying value stocks of companies that qualify for favorable federal income tax treatment. It benchmarks the performance of its portfolio against the Russell 1000 Value Index. Eaton Vance Tax-Advantaged Dividend Income Fund was formed on September 30, 2003 and is domiciled in the United States.

HQH

abrdn Healthcare Investors Shares of Beneficial Interest

Tekla Healthcare Investors is a closed-ended equity mutual fund launched and managed by Tekla Capital Management LLC. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the healthcare sector, including the biotechnology, medical devices, and pharmaceuticals industries. The fund primarily invests in growth stocks of small cap companies. It employs fundamental analysis with a focus on factors such as current or anticipated market position for services or products, experienced business management, recognized technological expertise, and the ability either to generate funds internally to finance growth or to secure outside sources of capital to create its portfolio. The fund benchmarks the performance of its portfolio against the NASDAQ Biotechnology Index, the S&P 500 Index, and the S&P 1500 Healthcare Index. It was previously known as H&Q Healthcare Investors. Tekla Healthcare Investors was formed on October 31, 1986 and is domiciled in the United States.

Latest EVT

Latest HQH